vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.
STURM RUGER & CO INC is the larger business by last-quarter revenue ($151.1M vs $83.1M, roughly 1.8× PROCEPT BioRobotics Corp). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 3.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 5.1%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
PRCT vs RGR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.1M | $151.1M |
| Net Profit | $-31.6M | — |
| Gross Margin | 64.9% | 17.8% |
| Operating Margin | -4.1% | 2.3% |
| Net Margin | -38.1% | — |
| Revenue YoY | 20.2% | 3.6% |
| Net Profit YoY | -27.9% | — |
| EPS (diluted) | $-0.56 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $83.1M | — | ||
| Q4 25 | $76.4M | $151.1M | ||
| Q3 25 | $83.3M | $126.8M | ||
| Q2 25 | $79.2M | $132.5M | ||
| Q1 25 | $69.2M | $135.7M | ||
| Q4 24 | $68.2M | $145.8M | ||
| Q3 24 | $58.4M | $122.3M | ||
| Q2 24 | $53.4M | $130.8M |
| Q1 26 | $-31.6M | — | ||
| Q4 25 | $-29.8M | — | ||
| Q3 25 | $-21.4M | $1.6M | ||
| Q2 25 | $-19.6M | $-17.2M | ||
| Q1 25 | $-24.7M | $7.8M | ||
| Q4 24 | $-18.9M | — | ||
| Q3 24 | $-21.0M | $4.7M | ||
| Q2 24 | $-25.6M | $8.3M |
| Q1 26 | 64.9% | — | ||
| Q4 25 | 60.6% | 17.8% | ||
| Q3 25 | 64.8% | 15.1% | ||
| Q2 25 | 65.4% | 3.9% | ||
| Q1 25 | 63.9% | 22.0% | ||
| Q4 24 | 64.0% | 22.8% | ||
| Q3 24 | 63.2% | 18.5% | ||
| Q2 24 | 59.0% | 22.3% |
| Q1 26 | -4.1% | — | ||
| Q4 25 | -40.6% | 2.3% | ||
| Q3 25 | -27.8% | -2.7% | ||
| Q2 25 | -28.0% | -15.6% | ||
| Q1 25 | -39.7% | 6.2% | ||
| Q4 24 | -28.9% | 7.8% | ||
| Q3 24 | -38.4% | 3.1% | ||
| Q2 24 | -50.3% | 6.9% |
| Q1 26 | -38.1% | — | ||
| Q4 25 | -39.1% | — | ||
| Q3 25 | -25.7% | 1.2% | ||
| Q2 25 | -24.7% | -13.0% | ||
| Q1 25 | -35.8% | 5.7% | ||
| Q4 24 | -27.6% | — | ||
| Q3 24 | -35.9% | 3.9% | ||
| Q2 24 | -48.0% | 6.3% |
| Q1 26 | $-0.56 | — | ||
| Q4 25 | $-0.54 | $0.22 | ||
| Q3 25 | $-0.38 | $0.10 | ||
| Q2 25 | $-0.35 | $-1.05 | ||
| Q1 25 | $-0.45 | $0.46 | ||
| Q4 24 | $-0.34 | $0.62 | ||
| Q3 24 | $-0.40 | $0.28 | ||
| Q2 24 | $-0.50 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.6M | $92.5M |
| Total DebtLower is stronger | $51.7M | — |
| Stockholders' EquityBook value | $347.7M | $283.8M |
| Total Assets | $487.1M | $342.0M |
| Debt / EquityLower = less leverage | 0.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.6M | — | ||
| Q4 25 | $286.5M | $92.5M | ||
| Q3 25 | $294.3M | $80.8M | ||
| Q2 25 | $302.7M | $101.4M | ||
| Q1 25 | $316.2M | $108.3M | ||
| Q4 24 | $333.7M | $105.5M | ||
| Q3 24 | $196.8M | $96.0M | ||
| Q2 24 | $214.1M | $105.6M |
| Q1 26 | $51.7M | — | ||
| Q4 25 | $51.6M | — | ||
| Q3 25 | $51.6M | — | ||
| Q2 25 | $51.5M | — | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | $51.4M | — | ||
| Q2 24 | $51.4M | — |
| Q1 26 | $347.7M | — | ||
| Q4 25 | $365.9M | $283.8M | ||
| Q3 25 | $380.3M | $279.6M | ||
| Q2 25 | $385.8M | $289.3M | ||
| Q1 25 | $389.2M | $321.5M | ||
| Q4 24 | $402.2M | $319.6M | ||
| Q3 24 | $241.2M | $314.9M | ||
| Q2 24 | $251.8M | $321.5M |
| Q1 26 | $487.1M | — | ||
| Q4 25 | $508.1M | $342.0M | ||
| Q3 25 | $511.5M | $342.3M | ||
| Q2 25 | $513.1M | $349.5M | ||
| Q1 25 | $519.4M | $379.0M | ||
| Q4 24 | $534.0M | $384.0M | ||
| Q3 24 | $374.1M | $373.5M | ||
| Q2 24 | $374.4M | $376.7M |
| Q1 26 | 0.15× | — | ||
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $15.5M |
| Free Cash FlowOCF − Capex | — | $12.3M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | — | 2.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $38.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-10.3M | $15.5M | ||
| Q3 25 | $-6.6M | $12.9M | ||
| Q2 25 | $-15.0M | $14.7M | ||
| Q1 25 | $-17.0M | $11.1M | ||
| Q4 24 | $-32.4M | $20.0M | ||
| Q3 24 | $-18.8M | $9.4M | ||
| Q2 24 | $-15.7M | $18.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-12.2M | $12.3M | ||
| Q3 25 | $-9.5M | $7.0M | ||
| Q2 25 | $-17.8M | $9.1M | ||
| Q1 25 | $-18.8M | $10.0M | ||
| Q4 24 | $-33.6M | $16.4M | ||
| Q3 24 | $-19.0M | $2.6M | ||
| Q2 24 | $-16.8M | $10.1M |
| Q1 26 | — | — | ||
| Q4 25 | -15.9% | 8.2% | ||
| Q3 25 | -11.4% | 5.5% | ||
| Q2 25 | -22.5% | 6.9% | ||
| Q1 25 | -27.2% | 7.4% | ||
| Q4 24 | -49.2% | 11.2% | ||
| Q3 24 | -32.6% | 2.1% | ||
| Q2 24 | -31.4% | 7.7% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 2.1% | ||
| Q3 25 | 3.4% | 4.6% | ||
| Q2 25 | 3.5% | 4.2% | ||
| Q1 25 | 2.7% | 0.8% | ||
| Q4 24 | 1.7% | 2.5% | ||
| Q3 24 | 0.4% | 5.5% | ||
| Q2 24 | 2.0% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
